Taro Pharmaceuticals U.S.A., Inc., the U.S.-based business of Israeli Pharma firm Taro Pharmaceutical Industries, Ltd., recalled a certain lot of epilepsy and bipolar disorder medication Lamotrigine in the form of tablets for the potential cross-contamination, the U.S. Food and Drug Administration revealed.
from RTT - Biotech https://ift.tt/2TgEOJr
via IFTTT
No comments:
Post a Comment